Feasibility of iNKT cell and PD-1+CD8+ T cell-based immunotherapy in patients with lung adenocarcinoma Preliminary results of a phase I/II clinical trial

von Cheng, Xiaobo
Veröffentlicht in: Clinical immunology (Orlando, Fla.) (2022)